Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis

Kidney International

Volumn 50, Issue 4, 1996, Pages 1230-1239

  Shankland, Stuart J ^a   Hugo, Christian ^b   Coats, Steve R ^b   Nangaku, Masaomi ^b   Pichler, Raimund H ^b   Gordon, Katherine L ^b   Pippin, Jeffrey ^b   Roberts, James M ^b   Couser, William G ^b   Johnson, Richard J ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN KINASE; CYCLINE; PROTEIN P21; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CONTROLLED STUDY; MALE; MESANGIUM; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; RAT;

EID: 10244265941     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.432     Document Type: Article

References (52)

1. KLAHR S, SCHREINER G, ICIKAWA I: Progression in renal disease. N Engl J Med 318:1657-1666, 1988
2. JOHNSON RJ: The glomerular response to injury: Progression or resolution. Kidney Int 45:1769-1782, 1993
3. FLOEGE J, BURNS MW, ALPERS CE, YOSHIMURA A, PRITZL P, GORDON K, SEIEERI RA, BOWEN-POPE DF, COUSER WG, JOHNSON RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 41:297-309, 1992
4. YAMAMOTO T, NOBLE NA, MILLER DE, BORDER WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
5. FUKUI MNT, EBIHARA I, NAGAOKA I, TOMINO Y: Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-β in experimental glomerular seleosis. J Lab Clin Med 121:224-234, 1992
6. FLOEGE J, ENG E, YOUNG BA, COUSER WG, JOHNSON RJ: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43: 369-380, 1993
7. FLOEGE J, JOHNSON RJ, GORDON KL, IIDA H, PRITZL P, YOSHIMURA A, CAMPBELL C, ALPERS CE, COUSER WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40:477-488, 1991
8. PARDEE AB: G1 events and regulation of cell proliferation. Science 246:603-608, 1989
9. SHERR CJ: G1 phase progression: Cycling on cue. Cell 79:551-555, 1994
10. MORGAN DO: Principles of CDK regulation. Nature 374:131-134, 1995
11. SHERR CJ: Mammalian G1 cyclins. Cell 73:1059-1065, 1993
12. OHTSUBO M, THEODORAS AM, SCHUMACHER J, ROBERTS JM, PAGANO M: Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15:2612-2624, 1995
13. PAGANO M, PEPPERKOK R, VERDE F, ANSORGE W, DRAETTA G: Cyclin A is required at two points in the human cell cycle. EMBO J 11:961-971, 1992
14. WEINBERG RA: The retinoblastoma protein and the cell cycle. Cell 81:323-330, 1995
15. SHERR CJ, ROBERTS JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163, 1995
16. INK4h is a potential effector of TGF-β induced cell cycle arrest. Nature 371:257-261, 1994
17. POLYAK K, KATO J, SOLOMON MJ, SHERR CJ, MASSAGUE J, ROBERTS JM, KOFF A: p27 kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8:9-22, 1994
18. HARPER JW, ADAMI GR, WEI N, KEYOMARSI K, ELLEDGE J: The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816, 1993
19. ABBOUD HE: Growth factors in glomerulonephritis. Kidney Int 43: 252-267, 1993
20. STERZEL RB, SCHULZE-LOHOFF E, MARX M: Cytokines and mesangial cells. Kidney Int 39:26-31, 1993
21. PREISIG PA, FRANCH HA: Renal epithelial hyperplasia and hypertrophy. Semin Nephrol 15:327-340, 1995
22. ISHIZAKI M, MASUDA Y, FUKUDA Y, SUGISAKI Y, YAMANAKA N, MASUGI Y: Experimental mesangioproliferative glomerulonephritis in rats induced by intravenous administration of anti-thymocyte serum. Acta Pathol Jpn 138:1191-1203, 1986
23. YAMAMOTO T, WISON CB: Complement dependence of antibody-induced mesangial cell injury in the rat. J Immunol 138:3758-3765, 1987
24. JOHNSON RJ, PRITZL P, IADA H, ALPERS CE: Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am J Pathol 138:313-321, 1991
25. SALANT DJ, DARBY C, COUSER WG: Experimental membranous glomerulonephritis in rats. J Clin Invest 66:71-81, 1980
26. SHANKLAND SJ, SCHOLEY JW: Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int 46:430-442, 1994
27. HUGO C, PICHLER R, MEEK R, GORDON K KT, FLOEGE J, BORNSTEIN P, WOUSER WG, JOHNSON RJ: Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int 48:1846-1856, 1995
28. DUIJVESTIN AM, VAN GORR H, KLATTER F, MAJOOR GD, VAN BUSSELE, VAN BREDA VRIESMAN PJC: Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody. Lab Invest 66:459-466, 1992
29. WALLENSTEIN S, ZUCKER CL, FLEISS JL: Some statistical methods useful in circulation research. Circ Res 47:1-9, 1980
30. PABST R, STERZEL RB: Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis. Kidney Int 24:626-631, 1983
31. NORBURY C, NURSE P: Animal cell cycles and their control. Annu Rev Biochem 61:441-471, 1992
32. LEES E: Cyclin dependent kinase regulation. Current Opin Cell Biol 7:773-780, 1995
33. KOBAYASHI H, STEWART E, POON R, ADAMCZEWSKI JP, GANNON J, HUNT T: Identification of the domains in cyclin A required for binding to, and activation of, p34cdc2 and p32cdk2 protein kinase subunits. Mol Biol Cell 3:1279-1294, 1992
34. PRELICH G, TAN CK, KOSTURA M, MATHEWS MB, So AG, DOWNEY KM, STILLMAN B: Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxillary protein. Nature 326:517-520, 1987
35. JEFFREY PD, RUSSO AA, POLYAK K, GIBBS E, HURWITZ J, MASSAGUE J, PAVLETICH NP: Mechanism of CDK activation revealed by the structure of a cyclin A-CDK2 complex. Nature 376:313-320, 1995
36. ROSENBLATT J, GU Y, MORGAN DO: Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc Nat Acad Sci USA 89:2824-2828, 1992
37. VAN GOOR H, DING G, KEES-FOLTS D, GROND J, SCHREINER GF, DIAMOND JR: Macrophages and renal disease. Lab Invest 71:456-464, 1994
38. IRUELA-ARIPSE L, GORDON K, HUGO C, DUIJVESTIN AM, CLAFFEY KP, REILLY M, COUSER WG, ALPERS CE, JOHNSON RJ: Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J PAthol 147:1715-1727, 1995
39. KATO J, MATSUOKA K, POLYAK K, MASSAGUE J, SHERR CJ: Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase-4 activating kinase. Cell 79:487-496, 1994
40. NOURSE J, FIRPO E, FLANAGAN WM, COATS S, POLYAK K, LEE M, MASSAGUE J, CRABTREE GR, ROBERTS JM: Interleukin-2-mediated elimination of the p27 kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573, 1994
41. TOYOSHIMA H, HUNTER T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74, 1994
42. NAKANISHI M, ADAMI GR, ROBETORYE RS, NODA A, VENABLE SF, DIMITROV D, PEREIRA-SMITH OM, SMITH JR: Exit from Go and entry into the cell cycle of cells expressing p21Sid1 antisense RNA. Proc Natl Acad Sci USA 92:4352-4356, 1995
43. EWEN ME, SLUSS HK, WHITEHOUSE LL, LIVINGSTON DM: TGFβ inhibition of CDK4 synthesis is linked to cell cycle arrest. Cell 74:1009-1020, 1993
44. REDDY KB, HOCEVAR BA, HOWE PH: Inhibition of G1 phase cyclin dependent kinases by transforming growth factor β1. J Cell Biochem 56:418-425, 1994
45. REDDY KB, HOCEVAR BA, HOWE PH: Inhibition of G1 phase cyclin dependent kinases by transforming growth factor β1. J Cell Biochem 56:418-425, 1994
46. ELBENDARY A, BERCHUCK A, DAVIS P, HAVRILESKY L, BAST RC, IGLEHART D, MARKS JR: Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Diff 5:1301-1307, 1994
47. CHEN J, JACKSON PK, KIRSCHNER MW, DUTTA A: Seperate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374:386-388, 1995
48. WAGA S, HANNON GJ, BEACH D, STILLMAN B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578, 1994
49. CHANG MW, BARR E, LU MM, BARTON K, LLIDIN JM: Adenovirus-mediated over-expression of the cyclin/cyclin dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J Clin Invest 96:2260-2268, 1995
50. HIRAMA T, KOEFFLER HP: Role of cyclin dependent kinase inhibitors in the development of cancer. Blood 86:841-854, 1995
51. FLOEGE J, ENG E, YOUNG BA, ALPERS CE, BARRETT TB, BOWENPOPE DF, JOHNSON RJ: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 92:2952-2962, 1993
52. OKUDA S, LANGUINO LR, ROUSLAKTI E, BORDER WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 86:453-462, 1990